Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis

Keyphrases

• Response to Treatment 100%
• Pruritus 100%
• Moderate-to-severe Psoriasis 100%
• Self-assessment Tool 100%
• Etanercept 30%
• Clinical Trials 20%
• Phase II Trial 20%
• Tumor Necrosis Factor-α Blocker 20%
• Confidence Interval 10%
• Patient Demographics 10%
• Patient-reported Outcomes 10%
• Psoriasis Treatment 10%
• Psoriasis 10%
• Psoriasis Area 10%
• Area Index 10%
• Psoriasis Severity 10%
• Severity Index 10%
• Kappa Coefficient 10%
• Common Symptoms 10%
• Test-retest Reliability 10%
• Standardized Response Mean 10%
• Valid Measurements 10%
• Pruritus Intensity 10%

Medicine and Dentistry

• Psoriasis 100%
• Pruritus 100%
• Self-Diagnosis 100%
• Etanercept 27%
• Clinical Trial 18%
• Tumor Necrosis Factor 18%
• Psoriasis Vulgaris 18%
• Phase III Trials 18%
• Patient Population 9%
• Effect Size 9%
• Kappa Statistics 9%
• Psoriasis Area and Severity Index 9%
• Test Retest Reliability 9%
• Patient-Reported Outcome 9%

Nursing and Health Professions

• Pruritus 100%
• Psoriasis 100%
• Self Evaluation 100%
• Etanercept 27%
• Tumor Necrosis Factor 18%
• Psoriasis Vulgaris 18%
• Patient Population 9%
• Patient-Reported Outcome 9%
• Confidence Interval 9%
• Effect Size 9%
• Kappa Statistics 9%
• Psoriasis Area and Severity Index 9%
• Test Retest Reliability 9%